Please check your internet connection and try again.
# Sodium Phosphate Enema
## Overview
Sodium phosphate enema is a hypertonic saline solution used as a stimulant laxative for the evacuation of the colon. It works by drawing water into the colon through osmosis, which softens stool and stimulates bowel contractions.
## Primary Indications
* Bowel preparation prior to colonoscopy, sigmoidoscopy, or barium enema.
* Relief of occasional constipation.
## Adult Dosing
* **Bowel Preparation:** Typically, a single 4.5 fluid ounce (133 mL) bottle is administered. For optimal results, follow specific instructions provided by the prescriber or facility protocol, which often involves administering the enema at a prescribed time before the procedure (e.g., evening before or morning of).
* **Constipation:** A single 4.5 fluid ounce (133 mL) bottle as a single dose.
## Pediatric Dosing
* **Ages 2-11 years:** 2.25 fluid ounces (67 mL) administered once.
* **Under 2 years:** Not recommended; consult a pediatrician.
## Dose Adjustments
* No dose adjustments are typically required based on renal or hepatic function for occasional use. However, caution is advised in patients with impaired renal function due to the risk of phosphate or sodium overload.
## Contraindications
* Congenital megacolon.
* Intestinal obstruction or perforation.
* Congenital or acquired megacolon.
* Severe renal impairment.
* Congestive heart failure.
* Hyperphosphatemia, hypocalcemia, or hypernatremia.
* Children younger than 2 years of age.
* Patients with impaired ability to retain the enema due to conditions such as anal or rectal fissures, ulcerative colitis, or a history of bowel surgery.
## Adverse Effects
* **Common:** Abdominal cramping, nausea, vomiting, bloating, anal irritation.
* **Serious:** Rectal bleeding, severe abdominal pain, dehydration, electrolyte disturbances (hyperphosphatemia, hypocalcemia, hypernatremia, hyponatremia), cardiac arrhythmias, seizures, renal failure.
## Key Drug Interactions
* **Diuretics:** Increased risk of dehydration and electrolyte imbalances.
* **Antihypertensives:** May mask symptoms of electrolyte imbalance.
* **Calcium-containing medications:** May contribute to hypercalcemia, especially in patients with renal impairment.
## Monitoring
* Monitor for signs and symptoms of dehydration and electrolyte imbalances (e.g., dizziness, dry mouth, decreased urine output, confusion, muscle weakness, palpitations).
* Monitor vital signs.
* In patients with renal impairment or risk factors for electrolyte disturbances, consider monitoring serum electrolytes and renal function.
## Clinical Pearls
* Ensure the patient understands administration instructions.
* Encourage adequate oral fluid intake before and after administration to prevent dehydration.
* Do not administer to patients with impaired rectal/anal function or conditions that preclude enema use.
* Repeated use or overuse can lead to dependence and electrolyte disturbances.
* Use with caution in the elderly and in patients with known or suspected cardiac, renal, or hepatic disease.
* The full contents of the enema should be retained for the time recommended by the manufacturer or healthcare provider (usually 5-15 minutes) to be effective.
---
*This information is for educational purposes only and does not substitute for professional medical advice. Always consult with a qualified healthcare provider to ensure the information provided is appropriate for your specific circumstances. Always verify current prescribing information with the manufacturer's product monograph.*
